$342 Million is the total value of Krensavage Asset Management, LLC's 12 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 9.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $56,914,000 | +25.4% | 364,274 | -8.1% | 16.62% | +15.0% |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $48,958,000 | +13.7% | 322,537 | -24.3% | 14.30% | +4.3% |
| TARO | Buy | TARO PHARMACEUTICAL INDUS | $40,649,000 | +37.9% | 553,646 | +3.0% | 11.87% | +26.5% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $39,712,000 | -13.8% | 82,200 | -0.1% | 11.60% | -20.9% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $36,156,000 | -4.3% | 858,811 | +4.1% | 10.56% | -12.2% |
| BIIB | Buy | BIOGEN INC | $33,795,000 | -13.1% | 138,017 | +0.6% | 9.87% | -20.3% |
| ALKS | Buy | ALKERMES PLC | $32,332,000 | +24.1% | 1,620,675 | +3.1% | 9.44% | +13.8% |
| MCK | Sell | MCKESSON CORP | $29,042,000 | +4.8% | 166,983 | -10.2% | 8.48% | -3.9% |
| SRGA | Buy | SURGALIGN HOLDINGS INC | $14,067,000 | +24.3% | 6,423,408 | +2.8% | 4.11% | +14.0% |
| IVC | Buy | INVACARE CORP | $8,096,000 | +22.2% | 904,547 | +2.7% | 2.36% | +12.1% |
| ANAB | Sell | ANAPTYSBIO INC | $2,375,000 | +35.5% | 110,448 | -7.1% | 0.69% | +24.4% |
| NXTC | New | NEXTCURE INC | $330,000 | – | 30,292 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.